Benzinga | Aug 10, 2021 04:00PM EDT

aTyr Pharma Q2 EPS $(0.64) Misses $(0.51) Estimate

aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.51) by 25.49 percent. This is a 7.25 percent increase over losses of $(0.69) per share from the same period last year.